Clinical Trial Update: Mononuclear Cells, Platelets and Zoledronic Acid for Preventing Collapse of the Femoral Head in Osteonecrosis [NA]

View source ↗

Summary

Clinical trial evaluating autologous mononuclear cells, platelets, and zoledronic acid to prevent collapse of the femoral head in osteonecrosis; current status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteonecrosis of the Femoral Head

Drugs mentioned

• Mononuclear Cells (mononuclear cells)
• Platelets (platelets)
• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Osteonecrosis | NA | Status: UNKNOWN